Financials

Discussions Technicals Seasonals

6872 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

NaviFUS Corp. operates as a medical device company. It provides solutions for crossing the blood-brain barrier (BBB) for enhanced oncology drug delivery. The firm's NaviFUS System, is designed to utilize non-invasive ultrasound energy to enable transient and safe enhancement of BBB permeability to facilitate the transport of small or large molecular CNS drugs to target tumor tissue at high precision for better treatment outcomes. The company was founded by Hao Li Liu in March 12, 2015 and is headquartered in Taipei, Taiwan.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

6872 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company